DEUTSCHE BANK AG\ - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 60 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$438,798
+17.4%
19,633
+12.9%
0.00%
Q2 2023$373,625
-37.9%
17,386
-30.7%
0.00%
Q1 2023$601,669
+58.7%
25,080
+53.4%
0.00%
Q4 2022$379,204
+47.6%
16,345
+1.8%
0.00%
Q3 2022$257,000
-20.7%
16,050
-12.2%
0.00%
Q2 2022$324,000
-23.0%
18,278
-11.6%
0.00%
Q1 2022$421,000
-0.9%
20,668
-9.1%
0.00%
Q4 2021$425,000
-4.1%
22,737
+1.4%
0.00%
Q3 2021$443,000
-92.1%
22,428
-90.6%
0.00%
-100.0%
Q2 2021$5,632,000
+215.9%
238,252
+216.7%
0.00%
+200.0%
Q1 2021$1,783,000
+245.5%
75,238
+192.0%
0.00%
Q4 2020$516,000
-27.1%
25,764
-24.4%
0.00%
Q3 2020$708,000
-46.6%
34,059
-55.0%
0.00%
-100.0%
Q2 2020$1,325,000
+201.1%
75,659
+180.8%
0.00%
Q1 2020$440,000
-83.8%
26,944
-79.7%
0.00%
-100.0%
Q4 2019$2,723,000
+44.8%
132,424
-19.3%
0.00%
+100.0%
Q3 2019$1,881,000
-25.4%
164,003
-14.5%
0.00%0.0%
Q2 2019$2,521,000
+384.8%
191,837
+455.8%
0.00%
Q1 2019$520,000
-28.3%
34,514
-18.4%
0.00%
-100.0%
Q4 2018$725,000
-65.4%
42,278
-70.3%
0.00%0.0%
Q3 2018$2,098,000
-74.8%
142,399
-59.2%
0.00%
-50.0%
Q2 2018$8,331,000
-3.0%
349,415
+3.9%
0.00%
-50.0%
Q1 2018$8,592,000
+12.4%
336,357
-18.8%
0.00%
-20.0%
Q4 2017$7,643,000
+1009.3%
414,115
+528.0%
0.01%
Q3 2017$689,000
-14.0%
65,946
+2.8%
0.00%
-100.0%
Q2 2017$801,000
+150.3%
64,121
+100.1%
0.00%
Q1 2017$320,000
-80.5%
32,038
-69.7%
0.00%
-100.0%
Q4 2016$1,643,000
-30.9%
105,662
-14.5%
0.00%
-50.0%
Q3 2016$2,379,000
+197.0%
123,628
+82.6%
0.00%
+100.0%
Q2 2016$801,000
+725.8%
67,697
+1148.1%
0.00%
Q1 2016$97,000
-16.4%
5,424
+26.6%
0.00%
Q4 2015$116,000
-74.0%
4,285
-78.9%
0.00%
Q3 2015$447,000
+1496.4%
20,269
+1164.4%
0.00%
Q2 2015$28,0001,6030.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2015
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders